UC researchers help demonstrate proof-of-concept gene therapy for hydrocephalus
October 14, 2026
A proof-of-concept study led by UC’s Agnes (Yu) Luo, PhD, and collaborators at UC Davis shows that an adeno-associated virus (AAV) gene therapy can reduce hydrocephalus-associated tissue damage in animal models, pointing to a potential new treatment strategy.
